apixaban

Poland

Drugs containing this active substance

  • ABATIXENT

    Abatixent is used in adults to prevent the formation of blood clots after hip or knee surgery, to prevent clots in the heart in people with an irregular heartbeat, and to treat and prevent the recurrence of deep vein thrombosis in the legs and pulmonary embolism. In children and adolescents, it is used to treat and prevent clots in the veins or pulmonary vessels.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 2.5 mg

    ATC: B01AF02

    Manufacturer: Lek Pharmaceuticals d.d. LEK S.A.

  • The medicine is used in adults to prevent blood clots in the heart (in cases of irregular heart rhythm) and for the treatment and prevention of deep vein thrombosis in the lower limbs and pulmonary embolism. In children and adolescents, it is used for the treatment and prevention of clots in the veins or pulmonary vessels.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 5 mg

    ATC: B01AF02

    Manufacturer: Lek Pharmaceuticals, d.d.

  • Aboxoma is used in adults to prevent deep vein thrombosis after hip or knee surgery, to prevent blood clots in the heart in people with atrial fibrillation, and to treat and prevent the recurrence of blood clots in the veins of the lower limbs and pulmonary vessels. In children and adolescents, it is used to treat and prevent blood clots in the veins or pulmonary vessels.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 2.5 mg

    ATC: B01AF02

    Manufacturer: Krka, d.d., Novo mesto

  • Aboxoma is used in adults to prevent blood clots in the heart (in cases of irregular heartbeat) and for the treatment and prevention of deep vein thrombosis in the lower limbs and pulmonary embolism. In children and adolescents, it is used for the treatment and prevention of clots in the veins or pulmonary vessels.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 5 mg

    ATC: B01AF02

    Manufacturer: Krka, d.d., Novo mesto

  • Apinoptim is used in adults to prevent deep vein thrombosis after hip or knee surgery and to prevent blood clots in the heart in people with atrial fibrillation. It is also used to treat blood clots in the veins of the lower limbs and pulmonary vessels, and to prevent their recurrence. In children and adolescents, it is used to treat and prevent blood clots in the veins or pulmonary vessels.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 2.5 mg

    ATC: B01AF02

    Manufacturer: Pharmadox Healthcare Limited

  • The medicine is used in adults to prevent blood clots in the heart (in atrial fibrillation) and in the treatment and prevention of clots in the veins of the lower limbs and pulmonary vessels. In children and adolescents, it is used for the treatment and prevention of clots in the veins or pulmonary vessels.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 5 mg

    ATC: B01AF02

    Manufacturer: Pharmadox Healthcare Limited

  • This medicine is used in adults to prevent blood clots after hip or knee replacement surgery, to prevent clots in the heart in people with an irregular heartbeat, and to treat and prevent the recurrence of deep vein thrombosis and pulmonary embolism. In children and adolescents, it is used to treat and prevent clots in the veins or lungs.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 2.5 mg

    ATC: B01AF02

    Manufacturer: Adamed Pharma S.A.

  • This medicine is used in adults to prevent blood clots in the heart (in people with atrial fibrillation) and in the treatment and prevention of deep vein thrombosis and pulmonary embolism. In children and adolescents, it is used for the treatment and prevention of clots in the veins or pulmonary vessels.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 5 mg

    ATC: B01AF02

    Manufacturer: Adamed Pharma S.A.

  • This medicine is used in adults to prevent blood clots after hip or knee replacement surgery and in patients with an irregular heartbeat (atrial fibrillation) to prevent clots in the heart. It is also used to treat deep vein thrombosis and pulmonary embolism and to prevent their recurrence. In children and adolescents, it is used to treat and prevent clots in the veins or pulmonary vessels.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 2.5 mg

    ATC: B01AF02

    Manufacturer: APL Swift Services (Malta) Ltd. Arrow Generiques Generis Farmacêutica, S.A.

  • This medicine is used in adults to prevent blood clots in the heart (in cases of irregular heartbeat) and for the treatment and prevention of deep vein thrombosis in the lower limbs and pulmonary embolism. In children and adolescents, it is used for the treatment and prevention of clots in the veins or pulmonary vessels.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 5 mg

    ATC: B01AF02

    Manufacturer: APL Swift Services (Malta) Ltd. Arrow Generiques Generis Farmacêutica, S.A.

  • The medicine is used in adults to prevent blood clots after hip or knee replacement surgery, to prevent blood clots in the heart in patients with an irregular heartbeat (atrial fibrillation), and to treat and prevent the recurrence of deep vein thrombosis and pulmonary embolism.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 2.5 mg

    ATC: B01AF02

    Manufacturer: Cipla Europe NV

  • This medicine is used in adults to prevent the formation of blood clots in the heart (in patients with atrial fibrillation and additional risk) and for the treatment and prevention of recurrence of deep vein thrombosis in the lower limbs and pulmonary embolism.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 5 mg

    ATC: B01AF02

    Manufacturer: Cipla Europe NV

  • This medicine is used in adults to prevent blood clots after hip or knee replacement surgery, to prevent clots in the heart in people with an irregular heartbeat, and to treat and prevent the recurrence of deep vein thrombosis and pulmonary embolism. In children and adolescents, it is used to treat and prevent clots in the veins or pulmonary vessels.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 2.5 mg

    ATC: B01AF02

    Manufacturer: Gedeon Richter Polska Sp. z o.o.

  • This medicine is used in adults to prevent blood clots in the heart (in cases of irregular heartbeat) and for the treatment and prevention of deep vein thrombosis in the lower limbs and pulmonary embolism. In children and adolescents, it is used for the treatment and prevention of clots in the veins or pulmonary vessels.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 5 mg

    ATC: B01AF02

    Manufacturer: Gedeon Richter Polska Sp. z o.o.

  • The medicine is used in adults to prevent blood clots after hip or knee replacement surgery, to prevent clots in the heart in people with an irregular heartbeat, and to treat and prevent the recurrence of deep vein thrombosis and pulmonary embolism. In children and adolescents, it is used to treat and prevent clots in the veins or pulmonary vessels.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 2.5 mg

    ATC: B01AF02

    Manufacturer: Laboratorios Liconsa S.A. Zentiva S.A.

  • The medicine is used in adults to prevent blood clots in the heart (in cases of irregular heartbeat) and for the treatment and prevention of deep vein thrombosis in the lower limbs and pulmonary embolism. In children and adolescents, it is used for the treatment and prevention of clots in the veins or pulmonary vessels.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 5 mg

    ATC: B01AF02

    Manufacturer: Laboratorios Liconsa S.A. Zentiva S.A.

  • The medicine is used in adults to prevent the formation of blood clots after hip or knee replacement surgery and in people with an irregular heartbeat (atrial fibrillation) to prevent clots in the heart. It is also used to treat deep vein thrombosis and pulmonary embolism, and in children (above 28 days of age) for the treatment and prevention of clots in the veins or lungs.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 2.5 mg

    ATC: B01AF02

    Manufacturer: Olpha

  • The medicine is used in adults to prevent blood clots in the heart (in people with atrial fibrillation) and in the treatment and prevention of recurrence of deep vein thrombosis in the lower limbs and pulmonary embolism. In children and adolescents, it is used for the treatment and prevention of clots in the veins or pulmonary vessels.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 5 mg

    ATC: B01AF02

    Manufacturer: Olpha

  • This medicine is used in adults to prevent deep vein thrombosis after hip or knee replacement surgery, to prevent blood clots in the heart in people with atrial fibrillation, and to treat and prevent the recurrence of blood clots in the veins of the legs and pulmonary vessels. In children and adolescents, it is used to treat and prevent blood clots in the veins or lungs.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 2.5 mg

    ATC: B01AF02

    Manufacturer: Orion Corporation

  • This medicine is used in adults to prevent blood clots in the heart (in atrial fibrillation) and for the treatment and prevention of deep vein thrombosis in the lower limbs and pulmonary embolism. In children and adolescents (from 28 days of age to 18 years), it is used for the treatment and prevention of venous or pulmonary clots.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 5 mg

    ATC: B01AF02

    Manufacturer: Orion Corporation

  • The medicine is used in adults to prevent the formation of blood clots after hip or knee replacement surgery, to prevent blood clots in the heart in people with an irregular heartbeat (atrial fibrillation), and to treat deep vein thrombosis and pulmonary embolism.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 2.5 mg

    ATC: B01AF02

    Manufacturer: Betapharm Arzneimittel GmbH

  • The medicine is used in adults to prevent the formation of blood clots in the heart (in people with atrial fibrillation and additional risk) and for the treatment and prevention of recurrence of blood clots in the veins of the lower limbs and in the blood vessels of the lungs.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 5 mg

    ATC: B01AF02

    Manufacturer: Betapharm Arzneimittel GmbH

  • This medicine is used in adults to prevent blood clots after hip or knee replacement surgery, to prevent clots in the heart in patients with atrial fibrillation, and for the treatment and prevention of recurrence of deep vein thrombosis and pulmonary embolism.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 2.5 mg

    ATC: B01AF02

    Manufacturer: Adalvo Limited Pharmadox Healthcare Limited

  • This medicine is used in adults to prevent blood clots in the heart (in patients with atrial fibrillation) and to treat and prevent the recurrence of blood clots in the veins of the lower limbs and in the blood vessels of the lungs.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 5 mg

    ATC: B01AF02

    Manufacturer: Adalvo Limited Pharmadox Healthcare Limited

  • This medicine is used in adults to prevent deep vein thrombosis after hip or knee replacement surgery, to prevent blood clots in the heart in patients with atrial fibrillation, and to treat and prevent the recurrence of blood clots in the veins of the legs and pulmonary vessels. In children and adolescents, it is used to treat and prevent blood clots in the veins or pulmonary vessels.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 2.5 mg

    ATC: B01AF02

    Manufacturer: Balkanpharma-Dupnitsa AD

  • This medicine is used in adults to prevent blood clots in the heart (in atrial fibrillation) and in the treatment and prevention of blood clots in the veins of the lower limbs and pulmonary vessels. In children and adolescents, it is used for the treatment and prevention of blood clots in the veins or pulmonary vessels.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 5 mg

    ATC: B01AF02

    Manufacturer: Balkanpharma-Dupnitsa AD

  • This medicine is used in adults to prevent deep vein thrombosis following hip or knee replacement surgery, to prevent blood clots in the heart in patients with atrial fibrillation, and to treat and prevent the recurrence of blood clots in the veins of the lower limbs and pulmonary vessels. In children and adolescents, it is used to treat and prevent blood clots in the veins or pulmonary vessels.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 2.5 mg

    ATC: B01AF02

    Manufacturer: Combino Pharm (Malta) Ltd.

  • This medicine is used in adults to prevent blood clots in the heart (in people with atrial fibrillation) and in the treatment and prevention of recurrence of deep vein thrombosis in the lower limbs and pulmonary embolism. In children and adolescents, it is used for the treatment and prevention of clots in the veins or pulmonary vessels.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 5 mg

    ATC: B01AF02

    Manufacturer: Combino Pharm (Malta) Ltd.

  • The medicine is used in adults to prevent blood clots in the heart (in case of irregular heartbeat) and in the treatment and prevention of clots in the leg veins and pulmonary blood vessels. In children and adolescents, it is used for the treatment and prevention of clots in the veins or pulmonary vessels.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 5 mg

    ATC: B01AF02

    Manufacturer: Sun Pharmaceutical Industries Europe B.V., Terapia S.A.

  • The medicine is used in adults to prevent deep vein thrombosis after hip or knee surgery, to prevent blood clots in the heart in people with atrial fibrillation, and to treat and prevent the recurrence of blood clots in the veins of the lower limbs and pulmonary vessels. In children and adolescents, it is used to treat and prevent blood clots in the veins or pulmonary vessels.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 2.5 mg

    ATC: B01AF02

    Manufacturer: Pharmadox Healthcare Limited

  • Avoclod is used in adults to prevent the formation of blood clots in the heart (in people with atrial fibrillation) and for the treatment and prevention of recurrence of thrombosis in the veins of the lower limbs and pulmonary vessels. In children and adolescents, it is used for the treatment and prevention of clots in the veins or pulmonary vessels.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 5 mg

    ATC: B01AF02

    Manufacturer: Pharmadox Healthcare Limited

  • The medicine is used in adults to prevent the formation of blood clots after hip or knee surgery, to prevent blood clots in the heart in patients with irregular heart rhythm, and to treat deep vein thrombosis and pulmonary embolism.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 2.5 mg

    ATC: B01AF02

    Manufacturer: Centrafarm Services B.V. STADA Arzneimittel AG

  • The medicine is used in adults to prevent the formation of blood clots in the heart (in patients with an irregular heart rhythm and an additional risk factor) and for the treatment and prevention of recurrence of thrombosis in the veins of the lower limbs and in the pulmonary vessels.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 5 mg

    ATC: B01AF02

    Manufacturer: Centrafarm Services B.V. STADA Arzneimittel AG

  • The medicine is used in adults to prevent deep vein thrombosis after hip or knee surgery and to prevent blood clots in the heart in people with an irregular heartbeat (atrial fibrillation). It is also used to treat blood clots in the veins of the lower limbs and pulmonary vessels and to prevent them from recurring. In children and adolescents, it is used to treat and prevent blood clots in the veins or pulmonary vessels.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 2.5 mg

    ATC: B01AF02

    Manufacturer: McDermott Laboratories Limited T/A Gerard Laboratories T/A Mylan Dublin Mylan Hungary Kft.

  • The medicine is used in adults to prevent blood clots in the heart (in the case of an irregular heartbeat) and in the treatment and prevention of deep vein thrombosis in the lower limbs and pulmonary embolism. In children and adolescents, it is used for the treatment and prevention of clots in the veins or pulmonary vessels.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 5 mg

    ATC: B01AF02

    Manufacturer: McDermott Laboratories Limited T/A Gerard Laboratories T/A Mylan Dublin Mylan Hungary Kft.

  • The medicine is used in adults to prevent the formation of blood clots after hip or knee surgery, to prevent blood clots in the heart in patients with an irregular heartbeat (atrial fibrillation), and to treat and prevent the recurrence of deep vein thrombosis and pulmonary embolism.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 2.5 mg

    ATC: B01AF02

    Manufacturer: PharmaPath S.A.

  • The medicine is used in adults to prevent the formation of blood clots in the heart (in patients with atrial fibrillation) and for the treatment and prevention of recurrence of thrombosis in the veins of the lower limbs and in the pulmonary blood vessels.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 5 mg

    ATC: B01AF02

    Manufacturer: PharmaPath S.A.

  • Elihib is used in adults to prevent blood clots after hip or knee replacement surgery, to prevent blood clots in the heart in people with atrial fibrillation, and to treat and prevent the recurrence of blood clots in the leg veins or pulmonary vessels. It is also used in children (over 28 days of age) for the treatment and prevention of blood clots in the veins or lungs.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 2.5 mg

    ATC: B01AF02

    Manufacturer: Adalvo Limited, G.L. Pharma Limited, Pharmadox Healthcare Limited

  • The medicine is used in adults to prevent blood clots in the heart (in atrial fibrillation) and in the treatment and prevention of clots in the veins of the lower limbs and pulmonary vessels. It is also used in children (above 28 days of age) for the treatment and prevention of clots in the veins or pulmonary vessels.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 5 mg

    ATC: B01AF02

    Manufacturer: Adalvo Limited, G.L. Pharma Limited, Pharmadox Healthcare Limited

  • The medicine is used in adults to prevent the formation of blood clots after hip or knee surgery, to prevent clots in the heart in people with atrial fibrillation, and to treat and prevent the recurrence of thrombosis in the leg veins or pulmonary vessels. It is also used in children (above 28 days of age) for the treatment and prevention of clots in the veins or lungs.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 2.5 mg

    ATC: B01AF02

    Manufacturer: Pharmadox Healthcare Limited

  • This medicine is used in adults to prevent the formation of blood clots in the heart (in cases of irregular heartbeat) and for the treatment and prevention of clots in the veins of the legs and pulmonary vessels. In children and adolescents, it is used for the treatment and prevention of clots in the veins or pulmonary vessels.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 5 mg

    ATC: B01AF02

    Manufacturer: Pharmadox Healthcare Limited

  • Erimpox is used in adults to prevent the formation of blood clots after hip or knee surgery and in people with an irregular heartbeat (atrial fibrillation) to prevent stroke. It is also used to treat deep vein thrombosis and pulmonary embolism and to prevent their recurrence. In children and adolescents, it is used to treat and prevent clots in the veins or pulmonary vessels.

    Form: capsules, hard

    Active substance Dosage
    apixaban 2.5 mg

    ATC: B01AF02

    Manufacturer: Adamed Pharma S.A.

  • The medicine is used in adults to prevent the formation of blood clots in the heart (in patients with atrial fibrillation) and for the treatment and prevention of recurrence of clots in the veins of the lower limbs and pulmonary vessels. In children and adolescents, it is used for the treatment and prevention of clots in the veins or pulmonary vessels.

    Form: capsules, hard

    Active substance Dosage
    apixaban 5 mg

    ATC: B01AF02

    Manufacturer: Adamed Pharma S.A.

  • The medicine is used in adults to prevent blood clots after hip or knee surgery, to prevent clots in the heart in people with irregular heartbeat, and to treat and prevent the recurrence of clots in the leg veins or pulmonary vessels. In children and adolescents, it is used to treat and prevent clots in the veins or pulmonary vessels.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 2.5 mg

    ATC: B01AF02

    Manufacturer: Mylan Germany GmbH, Mylan Hungary Ltd.

  • Fydoco is used in adults to prevent blood clots in the heart (in cases of irregular heartbeat) and in the treatment and prevention of blood clots in the veins of the legs and pulmonary vessels. In children and adolescents, it is used for the treatment and prevention of clots in the veins or pulmonary vessels.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 5 mg

    ATC: B01AF02

    Manufacturer: Mylan Germany GmbH, Mylan Hungary Ltd.

  • The medicine is used in adults to prevent the formation of blood clots (deep vein thrombosis) after hip or knee surgery, to prevent blood clots in the heart in people with irregular heartbeat, and to treat blood clots in the veins of the legs and pulmonary blood vessels.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 2.5 mg

    ATC: B01AF02

    Manufacturer: Adalvo Limited Pharmadox Healthcare Limited

  • The medicine is used in adults to prevent the formation of blood clots in the heart (in people with irregular heartbeat and additional risk) and for the treatment and prevention of clots in the veins of the legs and pulmonary blood vessels.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 5 mg

    ATC: B01AF02

    Manufacturer: Adalvo Limited Pharmadox Healthcare Limited

  • The medicine is used in adults to prevent the formation of blood clots after hip or knee surgery, to prevent blood clots in the heart in people with atrial fibrillation, and to treat and prevent the recurrence of thrombosis in the veins of the lower limbs or pulmonary vessels. In children and adolescents, it is used to treat and prevent blood clots in the veins or pulmonary vessels.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 2.5 mg

    ATC: B01AF02

    Manufacturer: Polpharma Pharmaceutical Works S.A.

  • Poltixa is used in adults to prevent the formation of blood clots in the heart (in the case of an irregular heartbeat) and in the treatment and prevention of deep vein thrombosis in the lower limbs and pulmonary embolism. In children and adolescents, it is used for the treatment and prevention of clots in the veins or blood vessels of the lungs.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 5 mg

    ATC: B01AF02

    Manufacturer: Polpharma Pharmaceutical Works S.A.

  • Prubdaq is used in adults to prevent blood clots after hip or knee replacement surgery and in patients with an irregular heartbeat (atrial fibrillation) to prevent clots in the heart. It is also used to treat deep vein thrombosis and pulmonary embolism, and in children and adolescents (above 28 days of age) for the treatment and prevention of clots in the veins or lungs.

    Form: tablets, film-coated

    Active substance Dosage
    apixaban 2.5 mg

    ATC: B01AF02

    Manufacturer: Polpharma Pharmaceutical Works S.A.